Bringing the fundamentals into focus…
Back to Cerus Corporation
How Cerus Corporation stacks up
CERS · against 454 other Healthcare companies listed in US-listed
Growth
59/ 100
Below the middle of the pack.
Ranked #250 of 455 · scores higher than 44% of peers
Bars: peers in each 10-point band of the growth score45 peers with a growth score of 50–59, including CERS · Click a bar to see the companies
Why growth scores 59?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- 3-year revenue growth is close to the peer norm. 3-year revenue growth: 8.4% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 70% of peers. Revenue growth: 14.3% vs peer median 6.1%
Metric by metric
Position: dot = CERS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CERS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 14.3% | 11.0% | 58% | 33% | |
| Earnings per share growthHigher is better · 171 reported | Not reported | 21.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 433 reported | 8.4% | 11.0% | 43% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around CERS| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 245 | 177.5B USD | 60 | 71 | |
| 245 | 588M USD | 60 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score